President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

In May 2025, the White House announced a ‘Most Favored Nation’ approach for setting prescription drug prices. The order aims ...

The Trump administration is demanding that pharmaceutical companies raise drug prices in Canada and other countries to ...

Trump’s main effort, which he cited on August 3, centers on getting drugmakers to offer the same price in the US as they do ...

Meanwhile, drugmakers ramp up U.S. manufacturing investments to navigate policy shifts and protect supply chain resilience.

Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the ...

Brazil has requested consultations at the World Trade Organization over tariffs imposed by U.S. President Donald Trump on the ...

Bio-Techne on Wednesday said it expects uncertainty related to U.S. President Donald Trump's tariff and academic funding policies to spill into its fiscal year 2026 and could create pressure on the ...

Our system provides the best of both worlds: development of new drugs and cheap options for most prescriptions. | Opinion ...

The administration wants drugmakers to bring medication prices more closely in line with the Most-Favored Nation pricing ...

Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing model for ...